Post Award Information
This award is intended support the development of independent investigators from low and middle-income countries with an interest in supporting country driven research priorities to meet sustainable development goals for people infected with or at risk for viral Hepatitis (B,C,D) and/or HIV. Please refer to the program Eligibility Criteria.
First Step
If you are chosen for an award, Gilead will contact you as we will need to set up a contract with your institution. You will also receive an invitation to present your research to the Scientific Review Committee, Gilead Medical Affairs colleagues, RSP Alumni, and your mentor.
One Year
One year after the contract starts, you'll be requested to present your progress virtually to the Scientific Review Committee along with the other awardees from your cycle. Upon project completion, you'll need to submit a final report (template provided) along with final financial documents. Any unused funds must be refunded to Gilead Sciences.
Ongoing
As an alumnus of the program, you'll be invited to future RSP events, which will help you build your networking skills and collaborate with your peers. You'll also be invited to join Gilead's Alumni community, a closed LinkedIn group. After the research is complete, Gilead may contact you each year to answer a few basic questions about its impact on your career and the scientific community which is important to demonstrate the value of the program.
Top FAQs
Institutional Review Board (IRB) approval is only required at the time of award disbursement. However a copy of the submission to the IRB must be submitted prior to the award.
The official start date is the date that the contract is signed by both your institution and Gilead Sciences. Award deference may be subject to country specific compliance regulations. If in doubt, please check with your institution.
In some cases, we can defer the start date of the award up to 4 months.
